CSL362

talacotuzumab · CSL Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CSL362, covering 2015-10-09 to 2015-10-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission [Phase 1]